11:10 AM EST, 11/04/2025 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) , up 3.3% on last look, said Tuesday that it will be presenting data showing "strong immune system engagement" inducing potent anti-cancer cell activity of its Bria-OTS+ platform in preclinical models.

The poster presentation will be held at the Society for Immunotherapy of Cancer Annual Meeting in Maryland on Nov. 7.

"Our data further validates the promise of our personalized cancer immunotherapy platform in advancing new treatments for cancer," said Dr William Williams, BriaCell chief executive.

"We look forward to evaluating these encouraging results in upcoming clinical studies of Bria-BRES+ for breast cancer and Bria-PROS+ for prostate cancer."

BriaCell shares are up $0.46, to $14.41, on the Toronto Stock Exchange.

Price: 14.41, Change: +0.46, Percent Change: +3.30